–
Monte Rosa Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−72.9
FY22:
−112
FY23:
−143
FY24:
−81.1
FY25:
−54.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−70.6
FY22:
−109
FY23:
−136
FY24:
−73.4
FY25:
−47.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−74.0
FY22:
−109
FY23:
−135
FY24:
−70.1
FY25:
−39.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−74.0
FY22:
−109
FY23:
−135
FY24:
−72.7
FY25:
−38.6
All amounts in millions USD